查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609150

被忽視的熱帶疾病診斷市場：按服務、疾病、診斷方法、最終用途分類 - 全球預測 2025-2030

Neglected Tropical Diseases Diagnosis Market by Service (Centralized Service, POC Service), Disease (African Trypanosomiasis, Buruli Ulcer, Chagas Disease), Diagnostic Method, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年被忽視的熱帶疾病診斷市場規模為66.9億美元，預計2024年將達到70.4億美元，複合年成長率為5.80%，2030年將達到99.3億美元，預計將達到1000萬美元。

被忽視的熱帶疾病 (NTD) 包括影響超過 10 億人的多種感染疾病，主要發生在熱帶和亞熱帶地區。被忽視的熱帶疾病是根據其對貧困人口的影響來定義的，是經濟和社會發展的主要障礙。對 NTD 準確診斷的需求證明了這些疾病會導致慢性健康問題、使人衰弱的感染疾病和社會恥辱。其應用範圍從基本診斷工具到先進的分子分析方法，對於疾病監測、有效的治療計劃和減少傳播至關重要。最終使用領域包括醫院、診斷實驗室和研究機構，它們使用這些診斷來管理集體爆發、指導醫療政策和進行流行病學調查。 NTD 診斷的市場成長是由全球衛生資金的增加、意識的提高和診斷技術的技術進步所推動的。加強強調早期檢測、準確診斷和具有成本效益的解決方案的官民合作關係和全球衛生措施正在為市場擴張提供機會。關鍵的成長要素包括政府和非政府投資的增加、分子和就地檢驗等診斷技術的創新以及受馬蘇病影響的地區獲得醫療保健的機會的擴大。然而，市場挑戰包括流行地區醫療基礎設施不足、意識有限、監管障礙以及先進診斷工具的高成本。開發低成本、快速的 NTD 診斷測試存在機會，特別是那些可以在資源匱乏的環境中進行的測試。創新可以集中在可提供快速、準確結果的攜帶式整合診斷平台上，也可以透過用於資料傳播和管理的數位健康技術來增強。為了利用這些商機，公司應專注於與政府和非政府組織的戰略合作夥伴關係，投資於新診斷方法的研發，並致力於可擴展的生產技術。為了在這個市場實現永續成長，公司必須進行實質審查，以適應嚴格的法規環境並解決醫療保健服務的障礙。

主要市場統計
基準年[2023] 66.9億美元
預計年份 [2024] 70.4億美元
預測年份 [2030] 99.3億美元
複合年成長率（%） 5.80%

市場動態：針對快速發展的被忽視的熱帶疾病診斷市場揭示的關鍵市場見解

被忽視的熱帶疾病診斷市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 解決被忽視的熱帶疾病的項目數量增加
    • 熱帶和亞熱帶國家被忽視的熱帶病患病率上升
    • 對疾病早期檢測的需求不斷成長
  • 市場限制因素
    • 欠低度開發國家缺乏對被忽視的熱帶疾病的治療意識
  • 市場機會
    • 不斷開發先進的被忽視熱帶疾病診斷設備
    • 活性化研究和開發，開發被忽視的熱帶疾病的創新診斷方法
  • 市場挑戰
    • 缺乏標準化診斷工具

波特五力：駕馭被忽視的熱帶疾病診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解被忽視的熱帶疾病診斷市場的外部影響

外部宏觀環境因素在塑造被忽視的熱帶疾病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解被忽視的熱帶疾病診斷市場的競爭格局

對被忽視的熱帶疾病診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 在被忽視的熱帶疾病診斷市場中的定位矩陣供應商績效評估

FPNV 定位矩陣是評估被忽視的熱帶疾病診斷市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了被忽視的熱帶疾病診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對被忽視的熱帶疾病診斷市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 解決被忽視的熱帶疾病的項目數量增加
      • 熱帶和亞熱帶國家經常被忽視的熱帶病患病率不斷上升
      • 對疾病早期檢測的需求不斷成長
    • 抑制因素
      • 開發中國家缺乏對被忽視的熱帶疾病的治療認知
    • 機會
      • 先進被忽視熱帶疾病診斷設備的開發進展
      • 加強研發力度，為被忽視的熱帶疾病開發創新診斷方法
    • 任務
      • 缺乏標準化診斷工具
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章被忽視的熱帶疾病診斷市場：依服務分類

  • 集中服務
  • 點對點服務

第7章被忽視的熱帶疾病診斷市場：依疾病分類

  • 非洲昏睡病
  • 布魯裡潰瘍
  • 南美錐蟲病
  • 屈公病
  • 登革熱
  • 麥地那蠕蟲病
  • 包蟲病
  • 食物中毒細菌
  • 利什曼原蟲症
  • 麻風
  • 淋巴絲蟲病
  • 盤尾絲蟲病
  • 狂犬病
  • 疥瘡
  • 血吸蟲病
  • 被蛇咬傷中毒
  • 土源性蠕蟲感染疾病
  • 絛蟲病/囊尾蚴病
  • 草莓瘤

第8章診斷方法被忽視的熱帶疾病診斷市場

  • 傳統方法
  • 分子/現代方法

第9章被忽視的熱帶疾病診斷市場：依最終用途分類

  • 臨床實驗室
  • 家庭保健
  • 醫院/診所

第10章 美洲被忽視的熱帶疾病診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區被忽視的熱帶疾病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲被忽視的熱帶疾病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Coris BioConcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche Ltd
  • Genome Diagnostics Pvt. Ltd.
  • InBios International, Inc.
  • Omega Diagnostics Group PLC
  • Ortho Clinical Diagnostics
  • Oscar Medicare Pvt. Ltd.
  • Premier Medical Corporation Ltd.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • ZeptoMetrix LLC
Product Code: MRR-742BD5181EB6

The Neglected Tropical Diseases Diagnosis Market was valued at USD 6.69 billion in 2023, expected to reach USD 7.04 billion in 2024, and is projected to grow at a CAGR of 5.80%, to USD 9.93 billion by 2030.

Neglected Tropical Diseases (NTDs) include a diverse array of infections affecting over a billion people primarily in tropical and subtropical regions. Defined by their impact on impoverished populations, they significantly hinder economic development and societal progression. The necessity of accurate NTD diagnosis underlies these diseases' ability to cause chronic health issues, debilitating infections, and societal stigma. Applications span from basic diagnostic tools to advanced molecular methodologies, crucial for disease surveillance, effective treatment planning, and transmission reduction. End-use sectors include hospitals, diagnostic laboratories, and research institutions, which utilize these diagnoses to manage outbreaks, guide healthcare policy, and conduct epidemiological studies. Market growth for NTD diagnoses is driven by increased global health funding, heightened awareness, and technological advancements in diagnostic techniques. A growing number of public-private partnerships and global health initiatives emphasize early detection, accurate diagnostics, and cost-effective solutions, presenting opportunities for market expansion. Key growth factors include increased governmental and non-governmental investments, innovation in diagnostic technologies like molecular and point-of-care testing, and expanding access to healthcare in regions burdened by NTDs. However, market challenges include inadequate healthcare infrastructure in endemic regions, limited awareness, regulatory barriers, and the high cost of advanced diagnostic tools. Opportunities exist in developing low-cost, rapid diagnostic tests for NTDs, particularly those deployable in low-resource settings. Innovation can focus on portable and integrated diagnostic platforms that provide quick and accurate results, potentially augmented by digital health technologies for data dissemination and management. To capitalize on these opportunities, companies should focus on strategic collaborations with governments and NGOs, invest in R&D for novel diagnostics, and work towards scalable production techniques. Due diligence must be executed in navigating stringent regulatory environments and addressing healthcare delivery barriers to sustainably grow within this market.

KEY MARKET STATISTICS
Base Year [2023] USD 6.69 billion
Estimated Year [2024] USD 7.04 billion
Forecast Year [2030] USD 9.93 billion
CAGR (%) 5.80%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Diseases Diagnosis Market

The Neglected Tropical Diseases Diagnosis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in number of programs to tackle neglected tropical diseases
    • Rising prevalence of neglected tropical diseases in tropical and subtropical countries
    • Growing demand for early disease identification
  • Market Restraints
    • Lack of neglected tropical diseases treatment awareness in underdeveloped countries
  • Market Opportunities
    • Growing development of advanced neglected tropical disease diagnosis devices
    • Rising R&D to develop innovative neglected tropical disease diagnosis
  • Market Challenges
    • Lack of standardization tools for diagnosis

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Diseases Diagnosis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Diseases Diagnosis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Diseases Diagnosis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Diseases Diagnosis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Diseases Diagnosis Market

A detailed market share analysis in the Neglected Tropical Diseases Diagnosis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Diseases Diagnosis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Diseases Diagnosis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Diseases Diagnosis Market

A strategic analysis of the Neglected Tropical Diseases Diagnosis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Diseases Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Bio-Rad Laboratories, Inc., Coris BioConcept SPRL, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt. Ltd., InBios International, Inc., Omega Diagnostics Group PLC, Ortho Clinical Diagnostics, Oscar Medicare Pvt. Ltd., Premier Medical Corporation Ltd., Siemens AG, Thermo Fisher Scientific Inc., and ZeptoMetrix LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Diseases Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Centralized Service and POC Service.
  • Based on Disease, market is studied across African Trypanosomiasis, Buruli Ulcer, Chagas Disease, Chikungunya, Dengue, Dracunculiasis, Echinococcosis, Foodborne Trematodiases, Leishmaniasis, Leprosy, Lymphatic Filariasis, Onchocerciasis, Rabies, Scabies, Schistosomiasis, Snakebite Envenoming, Soil-transmitted Helminth Infections, Taeniasis/Cysticercosis, and Yaws.
  • Based on Diagnostic Method, market is studied across Conventional Method and Molecular/Modern Method.
  • Based on End-Use, market is studied across Clinical Labs, Home Healthcare, and Hospitals /Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in number of programs to tackle neglected tropical diseases
      • 5.1.1.2. Rising prevalence of neglected tropical diseases in tropical and subtropical countries
      • 5.1.1.3. Growing demand for early disease identification
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of neglected tropical diseases treatment awareness in underdeveloped countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of advanced neglected tropical disease diagnosis devices
      • 5.1.3.2. Rising R&D to develop innovative neglected tropical disease diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of standardization tools for diagnosis
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neglected Tropical Diseases Diagnosis Market, by Service

  • 6.1. Introduction
  • 6.2. Centralized Service
  • 6.3. POC Service

7. Neglected Tropical Diseases Diagnosis Market, by Disease

  • 7.1. Introduction
  • 7.2. African Trypanosomiasis
  • 7.3. Buruli Ulcer
  • 7.4. Chagas Disease
  • 7.5. Chikungunya
  • 7.6. Dengue
  • 7.7. Dracunculiasis
  • 7.8. Echinococcosis
  • 7.9. Foodborne Trematodiases
  • 7.10. Leishmaniasis
  • 7.11. Leprosy
  • 7.12. Lymphatic Filariasis
  • 7.13. Onchocerciasis
  • 7.14. Rabies
  • 7.15. Scabies
  • 7.16. Schistosomiasis
  • 7.17. Snakebite Envenoming
  • 7.18. Soil-transmitted Helminth Infections
  • 7.19. Taeniasis/Cysticercosis
  • 7.20. Yaws

8. Neglected Tropical Diseases Diagnosis Market, by Diagnostic Method

  • 8.1. Introduction
  • 8.2. Conventional Method
  • 8.3. Molecular/Modern Method

9. Neglected Tropical Diseases Diagnosis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Labs
  • 9.3. Home Healthcare
  • 9.4. Hospitals /Clinics

10. Americas Neglected Tropical Diseases Diagnosis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neglected Tropical Diseases Diagnosis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neglected Tropical Diseases Diagnosis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Coris BioConcept SPRL
  • 4. DiaSys Diagnostic Systems GmbH
  • 5. F. Hoffmann-La Roche Ltd
  • 6. Genome Diagnostics Pvt. Ltd.
  • 7. InBios International, Inc.
  • 8. Omega Diagnostics Group PLC
  • 9. Ortho Clinical Diagnostics
  • 10. Oscar Medicare Pvt. Ltd.
  • 11. Premier Medical Corporation Ltd.
  • 12. Siemens AG
  • 13. Thermo Fisher Scientific Inc.
  • 14. ZeptoMetrix LLC

LIST OF FIGURES

  • FIGURE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET RESEARCH PROCESS
  • FIGURE 2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CENTRALIZED SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY POC SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CHIKUNGUNYA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DRACUNCULIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ECHINOCOCCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY FOODBORNE TREMATODIASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEISHMANIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY LYMPHATIC FILARIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY ONCHOCERCIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCABIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SCHISTOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SNAKEBITE ENVENOMING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SOIL-TRANSMITTED HELMINTH INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY TAENIASIS/CYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CONVENTIONAL METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY MOLECULAR/MODERN METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY HOSPITALS /CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 123. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 127. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. EGYPT NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 131. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 132. FINLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 135. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 136. FRANCE NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 139. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. GERMANY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 143. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. ISRAEL NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 147. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 148. ITALY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 152. NETHERLANDS NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 155. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. NIGERIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 159. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 160. NORWAY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 163. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. POLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 167. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 168. QATAR NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 171. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 172. RUSSIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 176. SAUDI ARABIA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH AFRICA NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 183. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. SPAIN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 187. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 188. SWEDEN NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 192. SWITZERLAND NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 195. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 196. TURKEY NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 204. UNITED KINGDOM NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023